For decades, researchers have worked to create drugs that teach the immune system to kill cancer cells the way traditional ...

Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

"The ability to trigger a robust, long-lasting immune response is a requisite feature for any cancer vaccine." Prostate ...

Scientists have uncovered new genetic clues that explain why some prostate cancers remain slow-growing while others become life-threatening.

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...

Compare those grim statistics with the overall five-year survival rates for breast and prostate cancers (91 ... whom will be infused with the anti-cancer vaccine while the other half will receive ...

A vaccine for pancreatic cancer could serve as a promising new therapy. At Memorial Sloan Kettering Cancer Center (MSK) in New York, an experimental approach to treating the cancer with a ...